Anumana Named to Fast Company’s 2024 Next Big Things in Tech Awards

CAMBRIDGE, Mass. – Nov. 19, 2024 – Anumana, a leading AI-driven health technology company, has been named to Fast Company’s 2024 Next Big Things in Tech list in the Health category. This distinction highlights Anumana’s work leveraging artificial intelligence (AI) to transform routine electrocardiograms (ECG) into tools that enable earlier diagnosis and treatment.

"We’re honored to be recognized by Fast Company for our work in advancing cardiovascular care through our ECG-AI algorithms,” said Maulik Nanavaty, CEO of Anumana. “This award reflects our leadership in developing evidence-based AI algorithms that empower physicians to detect diseases and intervene earlier. We believe that innovation like our ECG-AI low ejection fraction algorithm, trained, validated, and studied across more than 150,000 patients, is changing the landscape of heart health and setting new standards for patient care.”

Heart failure remains a leading cause of death and hospitalization globally, affecting nearly 6.7 million adults in the U.S. alone. Anumana’s FDA-cleared ECG-AI™ Low Ejection Fraction (LEF) algorithm uncovers insights from standard 12-lead ECG readings, enabling clinicians to diagnose and treat patients sooner. Currently available and recognized by the Centers for Medicare & Medicaid Services (CMS), the algorithm detects LEF—a key indicator of heart failure—without the onset of clear symptoms or conventionally identified ECG abnormalities.

The company’s expansive pipeline includes dozens of first-in-class algorithms, including FDA Breakthrough Device-Designated ECG-AI algorithms for detecting pulmonary hypertension, cardiac amyloidosis, and hyperkalemia. Anumana plans to bring numerous algorithms to the market next year in the U.S. and Europe. 

“The Next Big Things in Tech provides a fascinating glimpse at near- and long-term technological breakthroughs across a variety of sectors,” said Brendan Vaughan, editor-in-chief of Fast Company. “Spanning everything from semiconductors to agricultural gene editing, the companies featured in this year’s list are tackling some of the world’s most pressing and vexing problems.”

Fast Company’s Next Big Things in Tech highlights new technology breakthroughs that promise to help define the future of the industries they serve. This year, 138 technologies developed by established companies, startups, or research teams are featured for their potential to revolutionize the lives of consumers, businesses, and society overall. Click here to see the final list.

About Anumana 

Anumana is a leading AI-driven health technology company leveraging cutting-edge AI and industry-leading translational science to unlock the electrical language of the heart as never before. The company was founded by nference in collaboration with Mayo Clinic to leverage the clinical and technical expertise of both organizations to develop innovative ECG-AI technology into a clinically meaningful, medical-grade, and easy-to-use tool for clinicians to advance patient care. Anumana’s software-as-a-medical device (SaMD) ECG-AI™ solutions aim to detect diseases earlier using standard-of-care ECG readings, enabling clinicians to enhance and improve care with real-time AI insights. Anumana’s award-winning lead algorithm, ECG-AI™ LEF, is now available in the U.S. To learn more about how the algorithm can help clinicians identify LEF earlier and schedule a demo, visit us at ECG-AI LEF. For more information, visit www.anumana.ai or follow us on LinkedIn and X.

About Fast Company

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Brendan Vaughan. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication, Inc., and can be found online at fastcompany.com.

Anumana Media Contact

Andrea Sampson

President/CEO, Sampson Public Relations Group

asampson@sampsonprgroup.com